Evinacumab Cuts LDL-C in Children With Homozygous Familial Hypercholesterolemia
Evinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3
Home
Mirvetuximab Soravtansine Granted Priority Review for Ovarian Cancer
Mirvetuximab soravtansine is an antibody-drug conjugate comprised of a FRα-binding antibody, a cleavable linker, and a potent tubulin-targeting agent.
Exploring the Link Between Oral Health and Cardiovascular Disease
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
Antibiotics Unlikely for Chalazion, Hordeolum Resolution
Acute care centers were more likely to prescribe antibiotics for a chalazion, and older patients were more likely to receive antibiotics for a hordeolum.
Model Predicts Risk for Dysplasia After Eradication of Early Barrett Esophagus
To survey patients after successful treatment, researchers developed a prediction model for recurrent dysplasia after eradication of Barrett esophagus.
Optimizing Vision May Slow Cognitive Decline, Helping Prevent Dementia
100,000 US dementia cases could have been prevented by attending to vision health needs, a report suggests.
Annovera Product Supply Expected to Increase Following FDA Approval
According to the Company, these revisions will significantly reduce manufacturing batch rejections and increase future product supply.
Gentamicin-Eluting Bone Graft Substitute Gets FDA Clearance
Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler.
Dementia Risk in Patients With Atrial Fibrillation Tied to Diabetes, Stroke
Researchers sought to assess the risk factors for dementia in older adults with atrial fibrillation.
Study Evaluates Rise in US Astigmatism Rates
Researchers found a significant increase between 1999 and 2008 compared with astigmatism rates between 1971 and 1975.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Ophthalmology
Loading... 
Loading...